Dispatch Bio, a biotech company engineering a universal treatment across solid tumors leveraging its first-in-class Flare ...

Scientists have discovered how cells decide when to respond to physical forces, potentially opening new avenues for tackling ...

Cancer cells can disarm the immune system not just by hiding from it, but by actively reprogramming nearby immune cells into a suppressed state. This previously unrecognized molecular interaction, ...

Independent data monitoring committee (IDMC) determined the trial unlikely to meet primary endpoint – --Alector remains focused on advancing ...

Imagine a display that harvests ambient light when it is not actively in use, offsetting some of its own energy consumption.

When the liver fails, toxins—such as ammonia—that should be filtered from the blood build up and reach the brain. The result ...

Phase 1 Clinical Trial of EVOLVE104 Continues to Advance According to Plan Oral Minisymposium Presentation Demonstrates That EVOLVE T Cell Engagers Drive Greater T Cell Activation, Proliferation and ...

Scientists have discovered how cells decide when to respond to physical forces, potentially opening new avenues for tackling diseases such as cancer ...

OPKO Health, Inc. (NASDAQ: OPK) (OPKO) reports business highlights and financial results for the three months ended March 31, 2026. Highlights from the first quarter of 2026 and recent weeks included ...

Researchers discover that the protein Adgrl2 uses alternative splicing to switch between building brain synapses and sealing ...

Many of pomegranate's health benefits are attributed to its high antioxidant content. Here we're exploring all the pros of ...

Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases ...